HIGHLIGHTS
- who: Alexandra Rak and collaborators from the Institute of Experimental Medicine, Saint Petersburg, Russia Institute of Biomedical Systems and Biotechnology, Peter the Great Saint Petersburg Polytechnic University have published the paper: Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests, in the Journal: Viruses 2022, 2041 of /2022/
- what: This study was designed to assess the feasibility of using SARS-CoV-2 proteins as antigens in standard antibody tests in the context of constant viral evolution.
- how: The study suggests that the RBD-based serology . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.